Your browser is no longer supported. Please, upgrade your browser.
Settings
FWP Forward Pharma A/S daily Stock Chart
FWP [NASD]
Forward Pharma A/S
Index- P/E1.22 EPS (ttm)3.77 Insider Own0.17% Shs Outstand43.89M Perf Week2.22%
Market Cap201.89M Forward P/E- EPS next Y-0.09 Insider Trans0.00% Shs Float23.55M Perf Month-29.77%
Income939.90M PEG0.06 EPS next Q9.74 Inst Own21.70% Short Float0.48% Perf Quarter-81.10%
Sales1.25B P/S0.16 EPS this Y10.40% Inst Trans-1.35% Short Ratio1.26 Perf Half Y-76.43%
Book/sh4.98 P/B0.92 EPS next Y-103.60% ROA195.30% Target Price21.50 Perf Year-76.30%
Cash/sh32.82 P/C0.14 EPS next 5Y21.00% ROE230.00% 52W Range4.28 - 33.00 Perf YTD-69.33%
Dividend- P/FCF0.17 EPS past 5Y- ROI- 52W High-86.12% Beta-
Dividend %- Quick Ratio5.40 Sales past 5Y- Gross Margin- 52W Low7.01% ATR0.42
Employees12 Current Ratio5.40 Sales Q/Q- Oper. Margin- RSI (14)34.16 Volatility9.12% 7.96%
OptionableNo Debt/Eq0.00 EPS Q/Q632.50% Profit Margin75.20% Rel Volume0.31 Prev Close4.60
ShortableYes LT Debt/Eq0.00 EarningsNov 28 BMO Payout0.00% Avg Volume89.94K Price4.58
Recom3.00 SMA20-12.51% SMA50-27.18% SMA200-75.91% Volume26,816 Change-0.43%
Apr-03-17Downgrade JMP Securities Mkt Outperform → Mkt Perform
Apr-03-17Downgrade Jefferies Buy → Hold
May-26-15Reiterated RBC Capital Mkts Outperform $40 → $45
May-13-15Reiterated RBC Capital Mkts Outperform $33 → $40
May-07-15Reiterated Jefferies Buy $40 → $43
Apr-24-15Reiterated Leerink Partners Outperform $43 → $53
Apr-20-15Reiterated Leerink Partners Outperform $40 → $43
Nov-10-14Initiated RBC Capital Mkts Outperform $33
Nov-15-17 08:02AM  Best-In-Class Undervalued Stocks Simply Wall St.
Nov-09-17 04:30PM  Forward Pharma to Participate in the Nordic-American Life Science Conference GlobeNewswire
Oct-09-17 07:40AM  Featured Company News - AVEO Declares Completion of TIVO-3 Study Futility Analysis ACCESSWIRE
Sep-26-17 04:15PM  Forward Pharma Reports Financial and Operational Results from the First Six Months of 2017 GlobeNewswire
Sep-13-17 08:10AM  Today's Research Reports on Stocks to Watch: Atossa Genetics and Forward Pharma ACCESSWIRE -10.30%
Sep-08-17 08:56AM  Is It Time To Buy Forward Pharma A/S (FWP)? Simply Wall St.
Sep-05-17 05:00PM  Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit GlobeNewswire
Sep-01-17 07:00AM  Forward Pharma Board of Directors Approves Capital Reduction and Returns EUR 917.7 Million to Shareholders GlobeNewswire
Aug-02-17 04:45PM  Forward Pharma Obtains Shareholder Approval of the Planned Capital Reduction at the Extraordinary General Meeting GlobeNewswire
Jul-18-17 08:05AM  Forward Pharma announces planned distribution of EUR 19.45 per share to Shareholders GlobeNewswire
Jun-14-17 08:00AM  Forward Pharma CEO to Present at the JMP Securities 2017 Life Sciences Conference on June 20, 2017 GlobeNewswire
Jun-02-17 08:30AM  Forward Pharma CEO to Present at the Jefferies 2017 Global Healthcare Conference on June 6, 2017 GlobeNewswire
May-31-17 08:30AM  Forward Pharma Appeals the Initial Decision in the U.S. Patent Interference to the Federal Circuit GlobeNewswire
May-01-17 08:30AM  Forward Pharma CEO to Present at the 42nd Annual Deutsche Bank Health Care Conference on May 4, 2017 GlobeNewswire
07:30AM  Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement GlobeNewswire
Apr-18-17 05:15PM  Forward Pharma Reports Fourth Quarter and Year End 2016 Financial and Operational Results GlobeNewswire
Apr-07-17 08:33AM  Should Forward Pharma (FWP) Be On Your Radar Now? Zacks
Apr-03-17 03:42PM  Acorda, Forward, Biogen Fall On Multiple Sclerosis Drug Fight -8.28%
06:26AM  Forward Pharma A/S downgraded by JMP Securities and Jefferies
Mar-31-17 06:59PM  Forward Pharma Intends to Appeal Decision in Patent Interference Proceeding with Biogen Inc. GlobeNewswire -19.89%
05:14PM  Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today Motley Fool
05:14PM  Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today at Motley Fool
02:45PM  Biogen wins another big Tecfidera patent case at bizjournals.com
02:45PM  Biogen wins another big Tecfidera patent case American City Business Journals
01:02PM  Biogen wins Tecfidera U.S. patent dispute with Forward Pharma Reuters
12:27PM  Biogen stock rises, Forward Pharma halted down 20% after patent ruling MarketWatch
12:27PM  Biogen stock rises, Forward Pharma halted down 20% after patent ruling at MarketWatch
12:15PM  Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient Benzinga
12:10PM  Forward Pharma plunges on patent ruling CNBC Videos
Mar-01-17 09:15AM  Forward Pharma Appoints Claus Bo Svendsen as Chief Executive Officer and Plans to Reorganize to Reduce Burn Rate Following the Settlement and License Agreement with Biogen GlobeNewswire
Feb-09-17 08:30AM  Forward Pharma Received US$ 1.25bn pursuant to Settlement and License Agreement with Biogen GlobeNewswire
Feb-03-17 11:03AM  Why Forward Pharma A/S Stock Surged 107% in January Motley Fool -5.50%
11:03AM  Why Forward Pharma A/S Stock Surged 107% in January at Motley Fool
Feb-02-17 09:30AM  The Zacks Analyst Blog Highlights: Forward Pharma A/S, Pioneer Power Solutions, Hudbay Minerals, Applied Optoelectronics and Ultra Clean Holdings
Feb-01-17 02:22PM  5 Best Performing Stocks of January
09:15AM  Forward Pharma Announces Results of Extraordinary General Meeting GlobeNewswire
Jan-26-17 06:41AM  Biogen profit drops 22 pct due to Tecfidera-related costs
Jan-18-17 12:46PM  Biogen Inc. -- Moody's: Biogen's settlement with Forward Pharma is credit negative at Moody's
08:29AM  Why Forward Pharma A/S Stock Gained 48.2% on Tuesday at Motley Fool
08:02AM  Biogen to Pay $1.25B to Forward Pharma in Tecfidera Lawsuit
Jan-17-17 05:23PM  Why Clayton Williams Energy, Forward Pharma, and Luxottica Jumped Today at Motley Fool +48.23%
12:00PM  Forward Pharma Shares Jump on Biogen License Agreement
11:14AM  Biogen Pays Forward Pharma $1.25 Billion To Settle Tecfidera Suit
11:05AM  Tuesdays Top Biopharma Movers 24/7 Wall St.
11:01AM  Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen GlobeNewswire
10:05AM  Biogen to pay $1.25B settlement in multiple sclerosis drug case at bizjournals.com
09:45AM  [$$] Biogen Reaches Settlement and License Agreement for MS Drug at The Wall Street Journal
07:52AM  Forward Pharma stock skyrockets 53% on $1.25 bln cash licensing agreement with Biogen at MarketWatch
Jan-11-17 10:48AM  Will Forward Pharma (FWP) Continue to Surge Higher?
Dec-19-16 05:04PM  Biogen Names Insider New CEO After Five-Month Search, Stock Falls
Dec-15-16 08:15AM  Blog Coverage Protalix Receives Letter Intending Purchase of Alfataliglicerase to Treat Gaucher Patients in Brazil Accesswire -5.18%
Dec-13-16 05:43AM  Is Forward Pharma A/S (FWP) A Good Stock to Buy? at Insider Monkey -5.71%
Dec-06-16 10:06AM  Forward Pharma A/S :FWP-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016
Nov-30-16 04:22PM  Biogen, Forward Square Off In Multiple Sclerosis Patent Battle
Nov-29-16 04:34PM  Forward Pharma reports 3Q loss
04:15PM  Forward Pharma Reports Third Quarter 2016 Financial and Operational Results GlobeNewswire
Nov-02-16 08:00AM  Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November GlobeNewswire
Sep-14-16 08:39AM  Should You Get Rid of Forward Pharma (FWP) Now?
Sep-13-16 03:17PM  Forward Pharma A/S :FWP-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
Sep-06-16 08:00AM  Forward Pharma CFO to Participate in Three Investor Conferences in September GlobeNewswire
Sep-01-16 08:00AM  Forward Pharma Reports Second Quarter 2016 Financial and Operational Results GlobeNewswire
Jul-20-16 02:51PM  Biogen: This is Getting Annoying at Barrons.com
Jul-11-16 07:16PM  Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines
Jun-08-16 06:02PM  Forward Pharma A/S :FWP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
Jun-06-16 04:15PM  Forward Pharma CFO to Participate in Two Investor Conferences in June GlobeNewswire
Jun-02-16 04:15PM  Forward Pharma Reports First Quarter 2016 Financial and Operational Results GlobeNewswire
May-09-16 04:01PM  Forward Pharma Announces Board of Directors Expansion with Appointment of Two New Non-Executive Directors GlobeNewswire +9.84%
May-02-16 08:30AM  Forward Pharma CFO to Present at the Deutsche Bank Health Care Conference GlobeNewswire
Apr-16-16 01:04PM  FORWARD PHARMA A/S Financials
Apr-12-16 04:15PM  Forward Pharma Reports Fourth Quarter and Year End 2015 Financial and Operational Results GlobeNewswire
Mar-15-16 08:15AM  Forward Pharma (FWP) Jumps: Stock Adds 23.1% in Session
Feb-15-16 10:28AM  Billionaire Seth Klarmans Top Biotech Stock Picks at Insider Monkey
Feb-09-16 09:23AM  Forward Pharma CFO to Participate in Two Investor Conferences in February GlobeNewswire -10.30%
Dec-08-15 01:08PM  FORWARD PHARMA A/S Financials
Nov-30-15 02:50PM  Is Sturm, Ruger & Company (RGR) Going to Burn These Hedge Funds? at Insider Monkey
Nov-25-15 07:30AM  Forward Pharma Reports Third Quarter 2015 Financial and Operational Results GlobeNewswire +7.89%
Nov-24-15 10:43AM  Do Hedge Funds Love BJs Restaurants, Inc. (BJRI)? at Insider Monkey
Oct-14-15 10:57AM  What Happened To Billionaire Seth Klarmans Top Biotech Picks In The Third Quarter? at Insider Monkey
Sep-15-15 09:59AM  Diarrhea Dings Xenoport Psoriasis Drug Study Results at TheStreet
Sep-08-15 04:00PM  Forward Pharma Reports Second Quarter 2015 Financial and Operational Results GlobeNewswire
Sep-01-15 09:00AM  Forward Pharma CFO to Participate in Three Investor Conferences in September GlobeNewswire
Jun-19-15 08:30AM  Forward Pharma CFO to Present at the JMP Securities Life Sciences Conference GlobeNewswire
Jun-10-15 03:04PM  One Of Mark Lamperts Small-Cap Biotech Picks Has Returned 84% This Year And Its Not Done Yet at Insider Monkey
Jun-03-15 08:44AM  Will Forward Pharma (FWP) Continue to Surge Higher? - Tale of the Tape
May-21-15 08:52AM  Investors' Radars Failed to Catch Forward Pharma A/S (FWP), Has Yours? - Tale of the Tape
May-12-15 08:00AM  Forward Pharma Reports First Quarter 2015 Financial and Operational Results GlobeNewswire
May-01-15 10:56AM  Forward Pharma CFO to Present at Two Investor Conferences in May at noodls
10:40AM  Forward Pharma CFO to Present at Two Investor Conferences in May GlobeNewswire
Apr-27-15 10:12AM  Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe at noodls
10:05AM  Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe GlobeNewswire
Apr-15-15 06:10PM  Biogen Reports New Data from Acute Optic Neuritis Study - Analyst Blog
Apr-14-15 12:02PM  U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R) at noodls
11:22AM  U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R) GlobeNewswire
Apr-09-15 05:49PM  Forward Pharma Pre-IPO Investors Voluntarily Agree to Extend Lock-Up at noodls
05:31PM  Forward Pharma Pre-IPO Investors Voluntarily Agree to Extend Lock-Up GlobeNewswire
Mar-25-15 07:04AM  Forward Pharma Reports Fourth Quarter and Year End 2014 Financial and Operational Results at noodls
06:30AM  Forward Pharma Reports Fourth Quarter and Year End 2014 Financial and Operational Results GlobeNewswire
Mar-16-15 12:36PM  4 Stocks Breaking Out on Unusual Volume: Forward Pharma and More at TheStreet
08:50AM  Forward Pharma CFO to Present at the Future Leaders Conference on March 20th at noodls
08:30AM  Forward Pharma CFO to Present at the Future Leaders Conference on March 20th GlobeNewswire
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.